Open Access

Erratum to: Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in mid-Norway: a prospective observational study

  • Arne Mehl1, 2, 3Email author,
  • Bjørn Olav Åsvold3, 4, 5,
  • Angela Kümmel6,
  • Stian Lydersen7,
  • Julie Paulsen1, 3, 8,
  • Ingvild Haugan9,
  • Erik Solligård3, 10, 11,
  • Jan Kristian Damås3, 8, 12,
  • Stig Harthug13, 14 and
  • Tom-Harald Edna2, 15
BMC Infectious DiseasesBMC series – open, inclusive and trusted201717:446

https://doi.org/10.1186/s12879-017-2545-z

Received: 13 June 2017

Accepted: 13 June 2017

Published: 23 June 2017

The original article was published in BMC Infectious Diseases 2017 17:116

Erratum

After publication of the original article [1] the authors found the following errors had occurred:
  1. 1.

    The y-axis of Fig. 3 has been incorrectly titled ‘Percent’. The correct title is ‘Number of episodes’. (Fig. 3).

     
  1. 2.

    The legend of Fig. 3 did not contain correct information on the figure.

     
Fig. 3

Number of BSI episodes with microbe(s) non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail. The percentages of episodes with microbe(s) non-susceptible to PGM were 1.9%, 3.0%, and 5.2% in 2002–2005, 2006–2009, and 2010–2013, respectively. ANS, acquired non-susceptibility; INS, inherent non-susceptibility

The legend on Fig. 3 was originally labelled:

Microbes non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. (Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail) ANS, acquired non-susceptibility; INS, inherent non-susceptibility

However, this has been corrected to:

Number of BSI episodes with microbe(s) non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail. The percentages of episodes with microbe(s) non-susceptible to PGM were 1.9%, 3.0%, and 5.2% in 2002–2005, 2006–2009, and 2010–2013, respectively. ANS, acquired non-susceptibility; INS, inherent non-susceptibility (Fig. 3)

A corrected version of the figure is included in this Erratum:

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust
(2)
Unit for Applied Clinical Research, Department of Cancer Research and Molecular Medicine, NTNU, Norwegian University of Science and Technology
(3)
Mid-Norway Sepsis Research Group, Faculty of Medicine, NTNU, Norwegian University of Science and Technology
(4)
Department of Public Health, NTNU, Norwegian University of Science and Technology
(5)
Department of Endocrinology, St Olavs Hospital, Trondheim University Hospital
(6)
Department of Laboratory Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust
(7)
Regional Centre for Child and Youth Mental Health and Child Welfare – Central Norway, NTNU, Norwegian University of Science and Technology
(8)
Centre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, NTNU, Norwegian University of Science and Technology
(9)
Department of Medical Microbiology, St Olavs Hospital, Trondheim University Hospital
(10)
Clinic of Anesthesia and Intensive Care, St Olavs Hospital, Trondheim University Hospital
(11)
Department of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology
(12)
Department of Infectious Diseases, St Olav’s Hospital, Trondheim University Hospital
(13)
Department of Research and Development, Haukeland University Hospital
(14)
Department of Clinical Science, University of Bergen
(15)
Department of Surgery, Levanger Hospital, Nord-Trøndelag Hospital Trust

Reference

  1. Mehl A, Åsvold BO, Kümmel A, Lydersen S, Paulsen J, Haugan I, et al. BMC Infectious Diseases. 2017;17:116. doi:https://doi.org/10.1186/s12879-017-2210-6.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement